Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Canadian Assessment of Enbrel in Psoriasis
NCT00332332Phase 4Completed
- Sponsor
- Amgen
- Start
- Mar 2006
- Primary completion
- Jul 2009
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 4 trial of etanercept in plaque psoriasis, sponsored by Amgen. Started Mar 2006; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00332332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332332.